22-06-2012: University of Florida researchers have received a $1.5 million, five-year grant from the National Institutes of Health’s National Cancer Institute to examine the role of an inflammation-causing protein in colon cancer development.
Scientists suspect increased levels of the protein, called interleukin-8, or IL-8, may be partly to blame for increased rates of colon cancer among people who have ulcerative colitis, a condition that causes inflammation and bleeding in the lining of the colon and rectum.
If IL-8 is a culprit in cancer formation, scientists would focus on finding ways to disrupt its function and, in turn, halt the growth of colon cancer, said principal investigator Emina Huang, M.D., a colorectal surgeon and an associate professor in the UF College of Medicine’s department of surgery.
“We have known for a long time there is a clear relationship between cancer development and chronic inflammation in humans,” said Weiping Zou, M.D., Ph.D., a professor of surgery, immunology and biology and director for translational research at the University of Michigan. Zou is not involved in the UF research. “This is important, but not really very informative, because we really don’t know what’s going on. This project is trying to address this question by uncovering the cellular and the molecular mechanisms to explain why we have (that association). This is scientifically important.”
The work will focus on the role of IL-8 in the cells that line the inside of the colon. IL-8 is known to exist in cells called fibroblasts, which produce proteins that help “glue” the body’s tissues together. Scientists recently found that these cells contribute to the development of tumors in the colon.
In previous research, Huang and her team tested a different kind of tumor-initiating cell from the lining of the colon to see if they also contain the protein.
“To our surprise, they also made quite a bit of IL-8,” Huang said. “The reasons IL-8 is present are not clear. Researchers are trying to learn which cells are making IL-8 and why. Once this is determined, then it may be a therapeutic target.”
With the new grant, Huang and her collaborators will take the work a step further and test the effects of the protein on those tumor-initiating cells and examine the added influence of a second protein involved in cell binding, movement and death. They will also study whether higher levels of IL-8 are linked to a mutation that hinders the activity of a third type of protein that kills unhealthy cells. Left unchecked, such cells may create tumors.
Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages 9 to 17, from low-income families. They found that physician vaccin ... more
Pharmacy researchers at the University of Florida have isolated a new marine compound they believe may lead to improved drug therapies for pulmonary diseases by inhibiting their progression rather than managing their symptoms. Known as symplostatin 5, the compound was extracted from blue-gr ... more
A new way to test anti-hearing-loss drugs in people could help land those medicines on pharmacy shelves sooner. University of Florida researchers have figured out the longstanding problem of how to safely create temporary, reversible hearing loss in order to see how well the drugs work. The ... more
The feared Legionella pneumophila bacteria is responsible for legionellosis, an infectious disease that can lead to pneumonia. In order to infect us, this pathogen has developed a complex method enabling it to camouflage itself and go unnoticed in our cells, thus avoiding these acting again ... more
For leading a study that was the first to define appropriate bone density screening intervals for older women, Margaret Gourlay, MD, MPH, of the University of North Carolina School of Medicine has been honored with a Top 10 Clinical Research Achievement Award from the Clinical Research Foru ... more
Stem cells and tissue-specific cells can be grown in abundance from mature mammalian cells simply by blocking a certain membrane protein, according to scientists at the University of Pittsburgh School of Medicine and the National Institutes of Health (NIH). Their experiments, reported today ... more
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency—making important medical discoveries that improve health and save lives.